Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study

NCT04387656 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT04387656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04387656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Active, not recruiting
Start date
June 5, 2020
Completion date
October 3, 2026
Enrollment
1,877 (actual)
Sites
932

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 infection, hematopoietic and lymphatic system neoplasm, malignant solid neoplasm, metastatic malignant solid neoplasm